Creative Biolabs is skilled in NGS-based cancer research. We support one-stop cancer research services based on a variety of sequencing technologies. Our whole gene sequencing (WGS) and whole-exome sequencing (WES) platforms enable us to comprehensively analyze and identify known and unknown cancer gene mutations. Besides, we also provide high-quality target sequencing services, allowing us to analyze several or even hundreds of target gene mutations economically and effectively. Our services will facilitate our customers’ cancer research including cancer diagnosis and treatment.